Attached files
EXHIBIT 32
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
(Subsections (a) and (b) of Section 1350,
Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002
(subsections (a) and (b) of section 1350, chapter 63 of
title 18, United States Code), each of the undersigned officers of
MabVax Therapeutics Holdings, Inc., does hereby certify, to such
officer’s knowledge, that:
The Quarterly Report on Form 10-Q of MabVax Therapeutics Holdings,
Inc. for the three months ended March 31, 2017, fully complies
with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, and the information contained in
the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of MabVax
Therapeutics Holdings, Inc.
|
|
|
|
|
Date: May 22, 2017
|
By:
|
/s/ J. David Hansen
|
|
|
|
J. David Hansen
|
|
|
|
Chief Executive Officer (Principal
Executive Officer)
|
|
|
|
|
|
Date: May 22, 2017
|
By:
|
/s/ Gregory P. Hanson
|
|
|
|
Gregory P. Hanson
|
|
|
|
Chief Financial Officer (Principal
Financial and Accounting Officer)
|
A signed original of this written statement required by
Section 906 has been provided to the Company and will be
retained by the Company and furnished to the Securities and
Exchange Commission or its staff upon request.